Inactive Instrument
Quotes Celsion Corporation Nasdaq
Stocks
US15117N3052
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 24/09 | IMUNON, Inc. Presents Update On IMNN-001 Development Program For Women With Newly Diagnosed Advanced Ovarian Cancer | CI |
| 23/09 | Imunon, Inc. - Shareholder/Analyst Call |
Stock exchange
Basic data
Market Cap (USD)
66,77,569
Net sales (USD)
0
Free-Float
93.73%
Free-Float capitalization (USD)
62,58,630
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 66.78L | |
| -0.21% | -4.43% | +44.40% | +74.13% | 6.62TCr | |
| +0.82% | +5.41% | +8.05% | +73.53% | 5.52TCr | |
| -0.22% | +6.53% | +11.68% | +87.32% | 5.28TCr | |
| +3.28% | +5.58% | +26.51% | +50.05% | 4.55TCr | |
| +0.51% | +9.95% | +22.40% | +133.92% | 4.39TCr | |
| -1.15% | +0.39% | +263.21% | +594.60% | 4.16TCr | |
| +0.10% | +9.90% | +16.11% | +59.33% | 3.4TCr | |
| -7.13% | -5.67% | +28.08% | -0.59% | 2.58TCr | |
| +0.69% | +5.60% | +36.60% | +26.94% | 2.35TCr | |
| Average | -0.37% | +4.74% | +50.78% | +122.14% | 3.89TCr | |
| Weighted average by Cap. | -0.05% | +4.56% | +49.62% | +126.42% |
Historical Quotes: Celsion Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IMNN Stock
- Stock
- Quotes Celsion Corporation
Select your edition
All financial news and data tailored to specific country editions
